CompletedNCT06040944
Antipsychotic medicines and gum health in schizophrenia
About this title
Read the official source — NCT06040944Observational studyAges 20+Egypt
Understand this study
Who was this study for?
Listed age limits: from 20 years.
- Listed locations
- GizaSee all locations and recruitment
Study information
Study start dateStarted: September 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 64
- Sponsor
- Fayoum University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Egypt
- Age range
- Over 20 Years
- Official registry ID
- NCT06040944
- Official title
Show the full official title
The Effect of Antipsychotic Medication and the Associated Hyperprolactinemia as Risk Factor for Periodontal Diseases in Schizophrenic Patients: a Cohort Retrospective Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Giza
Questions about this study
Who is behind this study?
The study sponsor is Fayoum University, a university.
Did this study involve medication?
Yes. The study involved medication, including antipsychotic drugs inducing hyperprolactinemia.
Who was this study for?
Listed age limits: from 20 years.
